Publications by authors named "Clive Long"

Claim this Profile
C
Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.
Mark Jackson, Niousha Ahmari, Jianqiang Wu, Tilat A Rizvi, Elizabeth Fugate, Clive J Long

J Pharmacol Exp Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abdo-Man: a 3D-printed anthropomorphic phantom for validating quantitative SIRT.
Jonathan I Gear, Craig Cummings, Allison J Craig, Antigoni Divoli, Clive D C Long

EJNMMI Phys· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for incontinence in a secure psychiatric service for women.
Clive G Long, Rachel West, Rizwana Siddique, Samantha Rigg, Ellen Banyard

Int J Ment Health Nurs· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment progress in medium security hospital settings for women: changes in symptoms, personality and service need from admission to discharge.
Clive G Long, O Dolley, Clive R Hollin

Crim Behav Ment Health· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing an assessment of fire-setting to guide treatment in secure settings: the St Andrew's Fire and Arson Risk Instrument (SAFARI).
Clive G Long, Ellen Banyard, Barbara Fulton, Clive R Hollin

Behav Cogn Psychother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engagement in psychosocial treatment: its relationship to outcome and care pathway progress for women in medium-secure settings.
Clive Long, Olga Dolley, Clive Hollin

Crim Behav Ment Health· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic anorexia nervosa: a 4-year follow-up of adult patients treated in an acute inpatient setting.
Clive G Long, Kirsty-Anne Fitzgerald, Clive R Hollin

Clin Psychol Psychother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity.
Mark Baugh, Darcey Black, Paul Westwood, Emma Kinghorn, Kieran McGregor, Clive Long

J Autoimmun· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dealing with Feelings: the effectiveness of cognitive behavioural group treatment for women in secure settings.
Clive G Long, Barbara Fulton, Olga Dolley, Clive R Hollin

Behav Cogn Psychother· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka.
Wullie Arbuckle, Mark Baugh, Simone Belshaw, D Jonathan Bennett, John Bruin, Clive Long

Bioorg Med Chem Lett· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitors.
Jiaqiang Cai, John Robinson, Simone Belshaw, Kathryn Everett, Xavier Fradera, Clive Long

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERG.
Zoran Rankovic, Jiaqiang Cai, Jennifer Kerr, Xavier Fradera, John Robinson, Clive Long

Bioorg Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important.
Jiaqiang Cai, Xavier Fradera, Mario van Zeeland, Maureen Dempster, Kenneth S Cameron, Clive Long

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors.
Jiaqiang Cai, Mark Baugh, Darcey Black, Clive Long, D Jonathan Bennett

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing comorbid substance use in detained psychiatric patients: issues and instruments for evaluating treatment outcome.
Clive G Long, Clive R Hollin

Subst Use Misuse· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.
Zoran Rankovic, Jiaqiang Cai, Jennifer Kerr, Xavier Fradera, John Robinson, Clive Long

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dioxo-triazines as a novel series of cathepsin K inhibitors.
Zoran Rankovic, Jiaqiang Cai, Xavier Fradera, Maureen Dempster, Ashvin Mistry, Clive Long

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of a 'best practice' service for women in a medium-secure psychiatric setting: treatment components and evaluation.
Clive G Long, Barbara Fulton, Clive R Hollin

Clin Psychol Psychother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved methods for testing antiresorptive compounds in human osteoclast cultures.
Jukka P Rissanen, Hannele Ylipahkala, Katja M Fagerlund, Clive Long, H Kalervo Väänänen

J Bone Miner Metab· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of the CANFOR-S for measuring needs among mentally disordered offenders resident in medium or low secure hospital services in the UK: a pilot evaluation.
Clive G Long, Paula Webster, Jo Waine, Jamilah Motala, Clive R Hollin

Crim Behav Ment Health· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of equipment and methodology for whole body activity retention measurements in children undergoing targeted radionuclide therapy.
Sarah J Chittenden, Brenda E Pratt, Kay Pomeroy, Peter Black, Clive Long

Cancer Biother Radiopharm· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Destabilizing role of cathepsin S in murine atherosclerotic plaques.
Kenneth J Rodgers, Deborah J Watkins, Alastair L Miller, Peter Y Chan, Sharada Karanam, Clive J Long

Arterioscler Thromb Vasc Biol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis